Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
When Audiologists Lead, Patients Win
Level Up Your Practice at AAA 2026—Bring Your Assistant and Take Advantage of Exclusive Package Discounts! The Audiology Assistant Track is back by popular demand at AAA 2026,…
Utah Committee Removes Audiology Deregulation Language After Strong Professional Pushback
Early last week, the Utah Office of Professional Licensing Review (OPLR) released draft legislation proposing major revisions to the regulatory framework for licensure of multiple…
Academy Joins National Push for Inclusive Loan Rules for Health Professions
Late last month, the Academy signed onto a letter to the Department of Education and the Reimagining and Improving Student Education (RISE) rulemaking committee urging…


